HIV GP120 INHIBITS T-CELL ACTIVATION BY INTERFERING WITH EXPRESSION OF COSTIMULATORY MOLECULES CD40 LIGAND AND CD80 (B71)

Citation
N. Chirmule et al., HIV GP120 INHIBITS T-CELL ACTIVATION BY INTERFERING WITH EXPRESSION OF COSTIMULATORY MOLECULES CD40 LIGAND AND CD80 (B71), The Journal of immunology, 155(2), 1995, pp. 917-924
Citations number
47
Categorie Soggetti
Immunology
Journal title
The Journal of immunology
ISSN journal
00221767 → ACNP
Volume
155
Issue
2
Year of publication
1995
Pages
917 - 924
Database
ISI
SICI code
0022-1767(1995)155:2<917:HGITAB>2.0.ZU;2-7
Abstract
One mechanism of the immune suppression in HIV infection has been post ulated as being caused by the interaction of HIV envelope glycoprotein gp120 with CD4 molecules. Thus, pretreatment of purified peripheral b lood T cells or CD4(+) T cell clones with gp120 (or an anti-CD4 mAb) r esults in inhibition of anti-CD3 mAb-induced proliferative responses. In this study, we have analyzed the role of the interacting pairs of c ostimulatory molecules, CD28-B71 (CD80) and CD40 ligand (CD40L)-CD40, to elucidate further the mechanism of HIV gp120-induced inhibitory eff ects on T cell functions. Interactions between CD28-B71 and CD40L-CD40 were found to be essential for the anti-CD3 mAb-induced T cell prolif eration, as demonstrated by up-regulation of B71 and CD40L and the abi lity of anti-B71 and anti-CD40L mAbs to inhibit this response. Pretrea tment of CD4(+) T cells with gp120 before CD3 ligation with anti-CD3 m Ab resulted in failure of up-regulation of CD40L on T cells and B71 on APC. Exogenous addition of anti-CD28 mAb overcame the inhibitory effe ct of gp120 on anti-CD3 mab-induced T cell proliferation. We conclude that binding of gp120 to CD4 molecules on T cells may interrupt the se quential cascade of intercellular interaction involving 1) Ag/MHC clas s II-TCR/CD4, 2) CD40L-CD40, and 3) B71-CD28. These studies indicate t hat the CD4-gp120 interaction results in dysregulation of expression o f costimulatory molecules, CD40L, and B71 expression on T cells and AP C, respectively, thereby contributing to the T cell hyporesponsiveness in HIV infection.